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Abstract. This study evaluated the antioxidative effects of magnolol based on the mouse model induced by 
Enterotoxigenic Escherichia coli (E. coli, ETEC). All experimental mice were equally treated with ETEC 
suspensions (3.45×109 CFU/ml) after oral administration of magnolol for 7 days at the dose of 0, 100, 300 
and 500 mg/kg Body Weight (BW), respectively. The oxidative metabolites and antioxidases for each sample 
(organism of mouse) were determined: Malondialdehyde (MDA), Nitric Oxide (NO), Glutathione (GSH), 
Myeloperoxidase (MPO), Catalase (CAT), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx). 
In addition, we also determined the corresponding mRNA expressions of CAT, SOD and GPx as well as the 
Total Antioxidant Capacity (T-AOC). The experiment was completed with a theoretical study that predicts a 
series of 79 ChEMBL activities of magnolol with 47 proteins in 18 organisms using a Quantitative Structure- 
Activity Relationship (QSAR) classifier based on the Moving Averages (MAs) of Rcpi descriptors in three 
types of experimental conditions (biological activity with specific units, protein target and organisms). Six 
Machine Learning methods from Weka software were tested and the best QSAR classification model was 
provided by Random Forest with True Positive Rate (TPR) of 0.701 and Area under Receiver Operating 
Characteristic (AUROC) of 0.790 (test subset, 10-fold crossvalidation). The model is predicting if the new 
ChEMBL activities are greater or lower than the average values for the magnolol targets in different 
organisms. 
Keywords: QSAR model, Magnolol, Antioxidative activity, Reactive oxygen species, Machine learning, 
Random forest. 
 
 
 
  
1. INTRODUCTION 
Biological systems are frequently exposed to excessive reactive oxygen species (ROS), causing 
a disturbance into the natural antioxidant defense systems and, therefore, resulting in damage to all 
biomolecules, including nucleic acids, proteins, and lipids [1]. It is well known that 
lipopolysaccharides are capable of causing a wide variety of pathophysiological effects, due to the 
excessive production of proinflammatory cytokines and mediators, and the increased production of 
superoxide radical, lipid peroxides and nitric oxide results in ROS products [2]. Any additional 
burden of free radicals in animal and human physiological systems can tip the pro-oxidant and 
antioxidant balance, leading to oxidative stress. Currently, the antioxidant enzymes and 
lowmolecular- weight antioxidants are the two major antioxidant defense systems in animals and 
humans [3, 4]. Specifically, the compound magnolol is a main bioactive ingredient isolated from 
the cortex of Magnolol officinalis [5]. Accumulating evidence indicates that magnolol may play an 
important role in the treatment of various diseases due to its anticancer [6], anti-clastogenic [7], 
anti-inflammatory effects [8], and antioxidant activity, etc. [9-18]. It is noteworthy that the 
relevant magnolol studies have mainly focused on the evaluation of its beneficial effects against 
oxidative radicals in vitro. However, few studies have been conducted to comprehensively 
investigate the effects of magnolol on the antioxidant enzyme system in relation to oxidative stress 
in vivo.   
 
Consequently, the objectives of this study were the following. First, we carried out a short 
review about the activity of magnolol. Next, we reported new experimental studies to determine 
the anti-oxidative effects of magnolol on oxidative status, antioxidant enzyme activities, and 
antioxidant enzyme mRNA and protein expression in the livers of Enterotoxigenic Escherichia 
coli (ETEC)-induced and non-ETEC induced mice. Last, the experimental results are extended 
with a computational study for the prediction of magnolol biological activities against the protein 
targets in different organisms. Thus, a Quantitative Structure-Activity Relationships (QSAR) [19, 
20] was obtained as a Machine Learning [21] classifier that is able to predict that a specific 
ChEMBL activity [22] against a specific protein target into an organism is greater or lower than 
the average value for this activity in the dataset. Therefore, these predictions are completing the 
current experimental results in rat with new biological activities in new organisms, without the 
necessity of all the experimental combinations. This way, the theoretical method is a fast and 
cheap alternative to the experiments.  
 
The QSAR model is using as features the molecular descriptors [23] of the compounds that 
interacts with the protein targets. The coding of the molecular information into molecular 
descriptors has been demonstrated as a powerful method to create QSAR models for drugs, 
proteins or nucleic acids [24-26]: antiviral drugs [27-29], anti-microbial compounds [30-35], 
proteins [36-41], nucleic acids [42, 43] . The current study used compound descriptors and their 
moving averages (MAs) in three experimental conditions such as measuring ChEMBL activity 
(with units), protein target, and organism.  
2. SHORT REVIEW OF MAGNOLOL ACTIVITY  
Magnolol is the main bioactive ingredient isolated from the cortex of Magnolia officinalis [5]. 
Magnolol has been proved to act a vital role in dealing with various diseases. As a low-molecular-
weight antioxidant, magnolol is a hydroxylated biphenyl that can donate hydrogen atoms to the 
damaged molecules. Several previous studies have demonstrated that magnolol has a strong 
antioxidant ability to suppress the oxidation of lipid peroxidation [9] or to increase SOD activity to 
attenuate the oxidative damage [10]. ROS are an important inducer of the pathogenesis of these 
diseases and the therapeutic function of magnolol is tightly linked to its antioxidant effectiveness. 
Moreover, it has been reported that magnolol scavenges hydroxyl radical [11], peroxy-nitrite [12] 
and hydrogen peroxide [13] to reduce or suppress the generation of ROS. Furthermore, there is an 
additional direct evidence of its anti-oxidative effect on intracellular glutathione depletion [9] or 
enzymatic system capacity in mice [14].  
 
Lo et al. [15] demonstrated that magnolol and honokiol from Magnolia officinalis can protect 
rat heart mitochondria against lipid peroxidation. Thus, lipid peroxidation was induced in isolated 
rat heart mitochondria using Adenosine Diphosphate (ADP) and Ferrous Sulfate (FeSO4). The 
study showed that the antioxidant effect of magnolol was 1,000 times higher than that of α-
tocopherol and the magnolol demonstrated more free radical scavenging activity but less potent 
than α-tocopherol.  
 
Ke Yao et al. [16] used the Human Lens Epithelial (HLE) cells to study the protective effect of 
magnolol against hydrogen peroxide-induced oxidative stress. This study was determined by the 
role of the oxidative stress in the cataract’s progression. Thus, magnolol presented a protection 
effect H2O2-induced cytotoxicity in this type of cells by the inhibition of the ROS, the loss of 
mitochondrial membrane potential and the release of cytochrome c from mitochondria. Other 
effects of magnolol were observed: the inhibition of the H2O2-induced expressions of caspase-9 
and caspase-3, the attenuation of Extracellular Signal-Regulated Kinase/ Mitogen Activated 
Protein Kinase (ERK/MAPK) deactivation. In conclusion, magnolol was proposed as a protector 
against cataractogenesis.  
 
Another magnolol study demonstrated its neuroprotective activity in cultured rat cerebellar 
granule cell damage [17]. The neuron toxicity was induced by glucose deprivation, excitatory 
amino acids and hydrogen peroxide. As conclusion, the study showed that magnolol alone did not 
affect mitochondrial function or cell damage. Opposite, magnolol significantly reversed glucose 
deprivation-induced mitochondrial dysfunction and cell damage. Thus, the neuroprotective effects 
of magnolol could be related to its antioxidative activity and antagonism of excitotoxicity induced 
by excitatory amino acids. In conclusion, magnolol could be a potential therapeutic molecule 
against the neurodegenerative diseases.  
 
There is a high interest for natural molecules against aging. Therefore, magnolol is one of the 
bioactive compounds from natural resources against skin aging [18]. Skin aging involves the 
degradation of extracellular matrix (epidermal and dermal layers) with visible consequences in the 
skin surface and modifications of the skin physical properties. The importance of these molecules 
has implications in the treatment of chronological and premature skin aging. In addition to the 
magnolol, there are other phytomolecules for this task: aloin, ginsenoside, curcumin, epicatechin, 
asiaticoside, ziyuglycoside I, gallic acid, hydroxychavicol, hydroxycinnamic acids, 
hydroxybenzoic acids, etc. [18]. These molecules are scavenges of free radicals or they are 
preventing the trans-epidermal water loss, protecting the skin from wrinkles and keeping a 
younger skin.  
 
It is noteworthy that the relevant magnolol studies have mainly focused on the evaluation of its 
beneficial effects against oxidative radicals in vitro. However, few studies have been conducted to 
comprehensively investigate the effects of magnolol on the antioxidant enzyme system in relation 
to the oxidative stress in vivo. Consequently, the objectives of this study were to determine the 
anti-oxidative effects of magnolol on oxidative status, antioxidant enzyme activities, and 
antioxidant enzyme mRNA and protein expression in the livers of Enterotoxigenic Escherichia 
coli (ETEC)-induced and non-ETEC-induced mice.  
  
3. MATERIALS AND METHODS  
3.1. Experimental Methods  
3.1.1. Ethics Statement  
The administration of mice and all experimental procedures were carried out in accordance 
with the Laboratory Animal Ethical Commission and the Ethics Committee of the Institute of 
Subtropical Agriculture, Chinese Academy of Sciences (No. 015063506). All mice were 
slaughtered after anesthetizing with sodium pentobarbital, and all procedures were done within the 
minimize suffering.  
3.1.2. Extracts and Reagents  
The commercial magnolol power (extracted from the cortex of Magnolia officinalis, purity > 
98.0 % in dry) was purchased from Jinnong Bio Co. Ltd. (Changsha, China) and kept at -20°C. 
The ETEC O78:K80 (44813) suspensions (3.45×109 CFU/ml) was prepared in accordance with our 
previous report [44], and cultured overnight in lysogeny broth (LB) medium in a shaking incubator 
at 180 rpm and 37°C for 12 h. The cell density of ETEC suspension was measured by ND-1000 
UV-vis spectrophotometer (Nano- Drop Ltd., TX).  
3.1.3. Experimental Design  
The experimental animals made use of eighty BALB/c female mice with the ages of 7 - 8 
weeks and the average body weight of 20 - 22 g, purchased from Shanghai Laboratory Animal 
Center, the Chinese Academy of Science (SLACCAS, Shanghai, China). In the pre-experimental 
period, all mice were individually kept in a specific pathogen-free mouse colony in a standard 
environmental condition with the temperature of 20 - 30°C, relative humidity of 40 - 60%, and the 
light control cycle (illumination/dark) of 12h / 12h for 7 days. In addition, all mice had free access 
to autoclaved feed and sterile water.  
 
All animals (80 mice) were randomly divided into eight groups (n = 10 mice/group), including 
the group was or was not orally administered with 0.02 ml/g ETEC strain suspension, after the oral 
administration of magnolol for 7 days for all groups, at the dosages of 0, 100, 300, and 500 mg/kg 
mouse BW, respectively. The commercial magnolol power was equally dissolved in 0.4 ml 2% 
Tween 80 solution before oral administration by gavage for each mouse. The ETEC suspension 
was prepared according to our previous report [44], and the density was measured with ND-1000 
UV-vis spectrophotometer (NanoDrop Ltd., TX) at optical density 600 (OD 600=1 represents 1 × 
10
10
 CFU/ml cell density). In the present study, the determined cell density of ETEC suspension 
was 3.45×10
9
 CFU/ml. For the magnolol control groups, NC, M100, M300, M500 and ETEC, 
ME100, ME300, and ME500 represent whether the groups were or were not orally administered 
with ETEC suspension after orally administered with magnolol power at the dosages of 0, 100, 
300, and 500 mg/kg BW, respectively. Among, “M” represents the mice in a group were orally 
administered with magnolol solution, “E” represents the mice were intraperitoneally administered 
ETEC suspension (0.02 ml/g BW). Formal test period, all mice were orally administered with 
magnolol solution for 7 days according to the magnolol dosage of each group. All mice were 
fasted for 6 hours. After this time, an intraperitoneally ETEC suspension was administered. The 
animals in all groups were sacrificed under sodium pentobarbital anesthesia for 3 hours after the 
administration of ETEC suspension.  
  
3.1.4. Biochemical Analysis  
The liver tissue was sampled from each mouse and homogenized (1 g/10 ml ice-cold 0.9% 
sterile saline) on ice. The homogenized solution was centrifuged at 3,500 × g for 15 min at 4°C, 
and the supernatant was stored at -20°C for further analysis. Nitric oxide (NO), malondialdehyde 
(MDA), myeloperoxidase (MPO), total antioxidant capacity (T-AOC), glutathione (GSH), catalase 
(CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) in the supernatant of live 
samples were measured using spectrophotometric kits (A012, A003-1, A044, A015, A061, A007- 
1, A001-1, and A005) in accordance with the manufacturer’s instructions (Nanjing Jiancheng 
Bioengineering Institute, Nanjing, China) [14, 45].  
3.1.5. Real-time Quantitative RT-PCR  
Total RNA from the mouse livers was isolated using TRIzol reagent (Invitrogen, CA, USA) 
∆according to the manufacturer’s instructions within minor modification [44]. The concentration 
of isolated total RNA was quantified with an ND-1000 UV-vis spectrophotometer. Then, 1 μg of 
RNA was treated with RNase-free DNase I to remove DNA and cDNA was synthesized using a 
PrimeScript
TM
 RT reagent kit with gDNA Eraser (Takara Bio. Inc., Shiga, Japan). Primers (Table 
1) were designed using Primer 5.0 software (Premier Co., Canada) according to the mouse gene 
sequences. The glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal 
control to normalize target gene transcript levels. Real-time PCR was performed with SYBR
R
 
Premix Ex Tap
TM
 II (Tli RNaseH Plus) kits according to the manufacturer’s instructions [44]. 
Briefly, 1 μl cDNA template was added to a total volume of 10 μl containing 5 μl SYBR Green 
mix, 0.2 μl Rox, 3 μl DEPC-treated distilled water, and 0.4 μl each of the forward and reverse 
primers (10 nM). Reactions were conducted in an ABI 7900HT fast real-time qRT-PCR system 
using the following protocol: 95°C for 30 s for pre-denaturation, followed by 40 cycles of 95°C for 
5 s and 60°C for 30 s for amplification and quantification. To generate a melting curve, the 
temperature increased from 60°C to 95°C at a rate of 0.5
o
C over 10 s. At the end of the real-time 
PCR, the threshold cycle value (CT) for each reaction was provided, and the change in the 
transcriptional level of the target gene normalized to GAPDH was calculated by the following 
formula: relative mRNA level of target gene (folds of control) = 2-(∆∆CT), where ΔΔCT = (CT 
Target – CT GAPDH) treatment - (CT Target – CT GAPDH) control.  
Table 1. Sequences of primers (forward, for; reverse, rev), and size of real-time quantitative PCR products. 
Gene1  
Accession 
No. 
For Primers (5'- 3') Rev Primers (5'- 3') 
Product Size 
(bp) 
     
GAPDH  NM_008084 GACTCCACTCACGGCAAATTCA TCGCTCCTGGAAGATGGTGAT 93 
CAT  NM_009804 CGTTCGATTCTCCACAGTCA CCCACAAGATCCCAGTTACC 111 
CuZn-
SOD  
NM_011434 CGGATGAAGAGAGGCATGTT GTACGGCCAATGATGGAATG 124 
MnSOD  NM_013671 CAAGCGTGACTTTGGGTCTT GCGACCTTGCTCCTTATTGA 112 
ECSOD  NM_011435 TGTTCTACGGCTTGCTACTGG ATGCGTGTCGCCTATCTTCT 143 
GPx-1  NM_008160 AAGGCTCACCCGCTCTTTAC ACACCGGAGACCAAATGATG 106 
     
 
1GAPDH = glyceraldehyde-3-phosphate dehydrogenase; CAT = catalase; CuZn-SOD = superoxide dismutase 1; MnSOD = 
superoxide dismutase 2; ECSOD = superoxide dismutase 3; GPx-1 = glutathione peroxidase 1. 
  
3.1.6. Western Blot Analysis  
The total protein was extracted from the liver tissue using a total protein extraction kit, and the 
protein concentration was estimated using an enhanced Bicinchoninic Acid (BCA) protein assay 
kit (Beyotime Institute of Biotechnology Inc., Jiangsu, China). Equivalent quantities of protein 
were denatured at 100°C for 7 min and were separated by reducing 10% SDS-PAGE 
electrophoresis purchased from Beyotime Institute of Biotechnology Inc. The isolated proteins 
were transferred onto PVDF membranes (Millipore, MA, USA) with 0.45 μm apertures at a 
constant 200 mA for 70 min. The nonspecific binding sites of the membranes were blocked with 
5% non-fat milk in Tris-Tween buffered saline for 2 hours. The primary antibodies for SOD, CAT, 
GPx-1 and β-actin (Abcam Com., UK) were incubated with the membranes overnight at 4°C. 
Thereafter, they were subsequently incubated with horseradish peroxidase-conjugated secondary 
antibodies for 1 hour at room temperature before detection was performed by chemiluminescent 
reaction with Luminata TM Crescendo Western HRP Substrate (Merck Millipore, USA). 
Densitometric signals were obtained after the membranes were exposed to an X-ray film. The 
band intensities were quantified by Quantity One software (Bio-Rad) and normalized versus β-
actin as an internal control for total protein loading.  
3.2. Computational Methods  
In the theoretical study, a unique QSAR classification model has been developed using 
different types of Machine Learning techniques from Weka software [46]. The best model is able 
to predict magnolol ChEMBL activities for specific protein targets and organisms. The final model 
features are encoding the chemical information using molecular descriptors.  
 
The steps to find the best classification models for magnolol interactions prediction are the 
followings:  
 
1. Download of the initial dataset – from ChEMBL website, complete data was downloaded for 
all the interactions between the compounds and magnolol experimental targets (biological 
activity type, units of activity, SMILES formula for the compounds, protein target, organism);  
 
2. Create the QSAR model dataset:  
 
a. Calculation of 62 descriptors of the ChEMBL compounds using Rcpi package [47] from R 
programming language [48].  
 
b. Calculation of moving averages (MAs) for all descriptors using 3 experimental conditions: 
the type & units of the ChEMBL activity, protein target and organism. MAs are differences 
between the initial descriptors and the average values of the descriptors for a specific 
experimental condition. Thus, the final dataset has 186 features as MAs of the compound’s 
descriptors (62 descriptors * 3 experimental conditions).  
 
c. Search for the best QSAR model classification model based on compounds interactions 
with protein targets of magnolol using six Machine Learning techniques from Weka 
software: LibLINEAR [49], BayesNet [50], DecisionTable [51], RandomTree [52], J48 
[53], and RandomForest [54]. The criteria for the best model is the maximum true positive 
rate (TPR) and Area Under Receiver Operating Characteristic (AUROC) [55].  
 
d. Prediction of 79 ChEMBL activities of magnolol with 47 types of proteins in 18 organisms 
(Weka software).  
  
Let’s consider for each i compound that the output activity with specific units is unitAi and j 
molecular descriptors (j = 1-62) in specific experimental conditions (activity type, protein target 
and organism) are 
exper
Dij. The corresponding moving averages of the descriptors in three 
experimental conditions are 
activity
MADij, 
target
MADij and 
organism
MADij [
exper
MAD = 
exper
D – 
average(D)exper]. Thus, the general linear classifier Classi could be described by Eq. 1 (aij, bij, cij 
and a0 = linear coefficients).  
 
 
Class𝑖
+/−( 𝑒𝑥𝑝𝑒𝑟𝐴𝑖) = ∑ 𝑎𝑖𝑗 
.𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦MAD𝑖𝑗 +
62
𝑗=1
∑ 𝑏𝑖𝑗 
.𝑡𝑎𝑟𝑔𝑒𝑡MAD𝑖𝑗 + ∑ 𝑐𝑖𝑗 
.𝑜𝑟𝑔𝑎𝑛𝑖𝑠𝑚MAD𝑖𝑗 + 𝛼0
62
𝑗=1
62
𝑗=1
 (1) 
 
 
The initial activity values has been transformed into positive and negative classes as following: 
if the difference between the activity value of one case and the average values of the activity in the 
dataset is greater than zero, the class is positive (otherwise the class is negative). Thus, the QSAR 
classification model is able to predict of the values of the new compound activities are greater and 
lower than the average value of the activity in the dataset.  
 
The final dataset contains 38,468 cases with 186 features as 
exper
MADij (moving averages for 
each molecular descriptor in specific experimental condition). The default crossvalidation type in 
Weka was used (10-fold cross-validation). The best model was the classification model with 
maximum TPR and AUROC.  
 
The model could be used to predict for any compound with a SMILES formula the ChEMBL 
activity level for specific protein target and organism. Because the current experimental study was 
focused on magnolol, the QSAR model was used to complete these experiments by prediction of 
all activity types with all possible targets and organisms for magnolol. 
4. RESULTS AND DISCUSSION 
4.1. Experimental Study of ROS Activity of Magnolol 
4.1.1. Experimental Results 
The oxidative status of the livers of the mice was assessed by biochemical parameters, 
including MDA, MPO, NO, T-AOC and GSH (Fig. 1). Compared with the NC treatment, 
intraperitoneal administration of the ETEC suspension increased (P < 0.05) the production of 
MDA (Fig. 1A), MPO (Fig. 1B), NO (Fig. 1C) and T-AOC (Fig. 1D), but reduced (P < 0.05) the 
GSH level (Fig. 1E) in the livers of mice. Oral administration of magnolo at 100 mg/kg BW for 7 
days decreased (P < 0.05) the MPO level, and at 300 and 500 mg/kg BW, it increased (P < 0.05) 
the NO and GSH levels in the livers of the non-ETEC-induced mice. Compared with ETEC 
induction alone, magnolol pretreatment at a dose of 500 mg/kg BW significantly reduced (P < 
0.05) the MPO level, and magnolol pretreatment at all doses decreased (P < 0.05) the NO and T-
AOC levels in the livers of the ETEC-induced mice. 
  
 
 
 
Fig. (1). Concentrations of MDA (A), MPO (B), NO (C), T-AOC (D) and GSH (E) in non-ETEC-induced and ETEC-
induced mice. Values are the mean ± SEM. The values with different superscript letters significantly differ (P < 0.05). NC 
= normal control; ETEC = Enterotoxigenic Escherichia coli suspension-induced control; M100, M300, M500 = oral 
administration of magnolol at doses of 100, 300 and 500 mg/kg BW; ME100, ME300, ME500 = oral administration of 
magnolol at doses of 100, 300 and 500 mg/kg BW and then induction with the Enterotoxigenic Escherichia coli 
suspension. 
Compared with the NC group, SOD activity (Fig. 2A) and the mRNA expression of ECSOD 
(Fig. 2D) was significantly reduced (P < 0.05) in the mice that received intraperitoneal 
administration of the ETEC suspension, although the MnSOD (Fig. 2C) mRNA expression was 
dramatically increased (P < 0.05). Interestingly, the higher doses of magnolol treatment did not 
promote and instead inhibited (P < 0.05) SOD activity (500 mg/kg BW, Fig. 2A) and ECSOD 
mRNA expression (300 and 500 mg/kg BW, Fig. 2D), but the lower doses (100 and 300 mg/kg) of 
magnolol treatment markedly promoted (P < 0.05) CuZn-SOD mRNA expression (Fig. 2B). 
Compared with that in the ETEC group, CuZn-SOD mRNA expression was increased (P < 0.05) 
in the livers of the ETEC-induced mice that received magnolol pretreatment at doses of 100 and 
500 mg/kg BW (Fig. 2B), while ECSOD mRNA expression was increased in those that received 
doses of 300 and 500 mg/kg BW (Fig. 2D). 
  
 
 
 
Fig. (2). Effects of orally administered magnolol on SOD activity and relative SOD mRNA and protein expression in 
non-ETECinduced and ETEC-induced mice. Values are the mean ± SEM (n = 10). The values with different superscript 
letters significantly differ (P < 0.05). NC = normal control; ETEC = Enterotoxigenic Escherichia coli suspension-induced 
control; M100, M300, M500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg BW; ME100, ME300, 
ME500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg BW and then induction with the 
Enterotoxigenic Escherichia coli suspension. 
Compared with the NC treatment, the intraperitoneal administration of ETEC suspension or 
oral administration of magnolol did not affect (P > 0.05) the GPx activity, mRNA and protein 
expression in the livers of the ETEC-induced or non-ETEC-treated mice (Fig.3A, B and C), 
respectively. Compared to the corresponding levels in the ETEC group, GPx activity and mRNA 
expression were increased (P < 0.05) in the livers of the ETEC-induced mice that received 
magnolol pretreatment at 500 mg/kg BW (Fig. 3A and B). Additionally, there was a slight increase 
in GPx protein expression only in the ETEC-induced mice that received the 500 mg/kg BW 
magnolol treatment (Fig. 3C). 
  
 
 
 
Fig. (3). Effects of orally administered magnolol on GPx activity and relative GPx-1 mRNA and protein expression 
in non-ETECinduced and ETEC-induced mice. Values are the mean •± SEM (n = 10). The values with different 
superscript letters significantly differ (P < 0.05). NC = normal control; ETEC = Enterotoxigenic Escherichia coli 
suspension-induced control; M100, M300, M500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg 
BW; ME100, ME300, ME500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg BW and then 
induction with the Enterotoxigenic Escherichia coli suspension. 
Compared with the NC treatment, the intraperitoneal administration of the ETEC suspension 
reduced (P < 0.05) the activity and mRNA expression of CAT (Fig. 4A and B); however, the 
ETEC suspension infection did not affect CAT protein expression (Fig. 4C). Magnolol treatment 
at 300 and 500 mg/kg BW suppressed (P < 0.05) CAT activity but at 100 mg/kg BW, it promoted 
(P < 0.05) CAT mRNA expression in the livers of the non-ETEC-induced mice (Fig. 4A and B). 
Moreover, compared with ETEC induction alone, magnolol pretreatment at most levels (100, 300 
and 500 mg/kg BW) decreased (P < 0.05) the activity and mRNA expression of CAT (Fig. 4A and 
B). Subsequently, CAT protein expression (Fig. 4C) was not affected by magnolol treatment, 
regardless of whether the mice were treated with ETEC. 
  
 
 
 
Fig. (4). Effects of orally administered magnolol on CAT activity and relative CAT mRNA and protein expression in 
non-ETECinduced and ETEC-induced mice. Values are the mean •± SEM (n = 10). The values with different 
superscript letters significantly differ (P < 0.05). NC = normal control; ETEC = Enterotoxigenic Escherichia coli 
suspension-induced control; M100, M300, M500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg 
BW; ME100, ME300, ME500 = oral administration of magnolol at doses of 100, 300 and 500 mg/kg BW and then 
induction with the Enterotoxigenic Escherichia coli suspension. 
4.1.2. Discussion of Magnolol Activity 
In bio-systems, oxidative stress generally results from an imbalance between the pro-oxidative 
and anti-oxidative systems [1]. Previous studies have demonstrated that infection with enteric 
bacterial pathogens or the lipopolysaccharide induces inflammation [56], tissues damage and 
apoptosis and causes oxidative stress [57]. Several end products of lipid peroxidation have been 
used as biomarkers of oxidative stress, including MDA, NO and MPO [58, 59]. Total antioxidant 
capacity and GSH reflect the capacity of the nonenzymatic antioxidant defense system [59]. In this 
study, administration of the ETEC suspension increased the concentration of MDA, MPO, NO, 
and T-AOC, but reduced liver GSH levels in the liver tissue, further indicating that ETEC 
infection partly caused liver damage and induced lipid peroxidation, indicating that the livers of 
the experimental mice may be experiencing oxidative stress. 
 
It has been reported that magnolol can decrease MDA concentrations in rat ileum after 
lipopolysaccharide injection [57] or in diabetic rats liver [11]. This supported the current results 
where magnolol reduced the MDA concentrations in the livers of mice with ETEC induction. The 
current results showed that magnolol treatment reduced MPO levels in mice with or without ETEC 
induction, in agreement with the previous report [12]. Interestingly, the increase in NO caused by 
higher doses of oral magnolol may be related to the prooxidative capacity of magnolol in non-
ETEC-induced mice; these results are partly consistent with the previous findings, in which a 
significant pro-oxidative effect could be easily triggered by treatment with higher doses of 
flavonoid or vitamin E [60, 61]. In oxidative stress, magnolol can effectively reduce NO levels in 
the rat hind limb muscle model [12] which supported the results of the magnolol pretreatment at 
all of the administered doses reducing NO levels in ETEC-induced mice. Of note, the T-AOC 
levels were reduced by oral magnolol in the ETEC-induced mice, while our previous study 
reported that magnolol treatment increased liver T-AOC levels in physiologically normal mice 
[14]. The possible explanations were that magnolol may restore the T-AOC levels in the bacteria 
induced oxidative stress. GSH levels were continuously increased by oral magnolol at different 
doses in the non-ETEC-induced mice supporting our previous report [14]. The previous study has 
demonstrated that magnolol treatment alleviated the GSH depletion in rat liver tissue induced by 
acetaminophen [9]. Pretreatment with quercetin for 15 days resulted in a significant increase in the 
hepatic GSH concentration, but the protective effects were not observed when the mice were 
treated with quercetin after chronic exposure to ethanol [62]. Some studies have indicated that 
GSH has the capacity to directly scavenge hydroxyl radical and singlet oxygen; acting as a 
cofactor of several detoxifying enzymes, glutathione peroxidase, and others; participating in amino 
acid transport; and regenerating the most important antioxidants (e.g., vitamins C and E) [1, 63]. It 
was observed that magnolol did not restore the GSH depletion in ETEC-induced mice. To some 
extent, we propose that magnolol has unique effects on NO, T-AOC and GSH activity under 
normal physiological or pathological conditions due to their multiple effects in all of the lines of 
protection against oxidative stress [3].  
 
Obviously, the present study revealed some novel evidences that magnolol played a different 
role in modulating the relevant antioxidant enzymes. For instance, magnolol raised the mRNA 
expression of soluble superoxide dismutase 1 (CuZn-SOD), but reduced SOD activity and the 
mRNA expression of extracellular superoxide dismutase 3 (ECSOD) in non-ETEC-induced mice. 
Interestingly, these results were partly different with our previous results that the mRNA 
expression of CuZn-SOD and superoxide dismutase 2 or mitochondrial (MnSOD) were not altered 
after 14 days of magnolol administration in Kunming mice, although total SOD activity and 
ECSOD mRNA expression were increased [14]. Simultaneously, administration of the ETEC 
suspension reduced total SOD activity and ECSOD mRNA expression but increased MnSOD 
mRNA expression. However, magnolol had significant antioxidant effects on total SOD activity or 
mRNA (e.g., CuZn-SOD and ECSOD) and protein expression in ETEC-induced mice which was 
in agreement with the previous reports [7, 11, 57]. Based on the previous studies of flavonoids and 
polyphenols, it might be surmised that the effects of antioxidants depend on different factors, such 
as the specific compound used, the cell type, the dose, and the experimental design [3, 4, 60, 61]. 
Therefore, based on this fact together with the data of SOD activity and mRNA and protein 
expression, we suggest that magnolol played a different role in SOD-mediated enzymatic 
antioxidant defense against superoxide radicals.  
 
The low oral dose of magnolol caused a numerical increment in hepatic antioxidant enzymatic 
activity and the mRNA and protein expression of GPx; these effects were partially validated by 
our previous report in the physiological mouse liver [14]. In contrast, oral magnolol 500 mg/kg 
BW predominantly increased the antioxidant activity and mRNA expression of GPx in ETEC-
induced mice. To some extent, these results do not conflict with the former report, in which the 
oral magnolol significantly increased the hepatic antioxidant activity of GPx in diabetic rats [11]. 
A reasonable explanation is that the antioxidant capacity of magnolol in different 
pathophysiological conditions depends on the dose.  
 
CAT has been shown to be regulated at multiple levels by diverse polyphenols. For instance, 
feeding rats a 2% garlic diet for 2 weeks reduced CAT activity and its protein expression level, 
whereas the CAT mRNA level remained unchanged in the kidney and liver [64]. Moreover, 
resveratrol was shown to inhibit the mRNA expression of CAT in rotifers [65]. In addition, oral 
administration of magnolol significantly increased the hepatic activity of CAT in the livers of 
diabetic rats [11] and increased the activity and mRNA level of CAT in normal mice [14]. Oral 
magnolol decreased the activity of CAT in ETEC-induced or non- ETEC-induced mice, while it 
increased the CAT mRNA level in non-ETEC-induced mice, but decreased CAT mRNA and 
protein expression in a dose-dependent manner in ETEC-induced mice. This evidence suggests 
that CAT could be modulated and controlled by magnolol, an effect that distinguishes it from other 
polyphenols, in a manner strongly dependent on the dose and the pathophysiological condition. 
4.2. QSAR Model for Magnolol ChEMBL Protein Targets  
The experimental results have been completed with computational study for the evaluation of 
the interactions of magnolol by different ChEMBL activities with different protein targets in 
organisms. The main dataset was obtained for the molecules with the activities against magnolol 
protein targets, in specific organisms. This data was completed with the molecular Rcpi 
descriptors.  
 
Moving averages of these descriptors for types of activities, protein targets and organism were 
the final features of the models. The output values of activities were transformed in two classes 
using the averages values of each activity type: positive class for the cases where the values are 
greater than the averaged one and negative class for opposite cases. The prediction is using 
Machine Learning classifiers that are able to predict if a specific ChEMBL activity of magnolol is 
greater or less than the average value of the dataset activities.  
 
Six Machine Learning classification methods were tested by Weka software: LibLINEAR, 
BayesNet, DecisionTable, RandomTree, J48, and RandomForest. The values of TPR and AUROC 
for each classifier are presented in Table 2. The results show that linear models are not enough to 
describe the relation between the output and the features. Bayes Nets gives better results but it has 
a very low performance. The rules method such as Decision Table is slowly improving the 
classification performance compared with Bayes Net but with TPR < 0.64 and AUROC < 0.71. 
The next three methods are based on trees: Random Tree, J48 and Random Forest. The results 
demonstrate that the methods based on one single tree (Random Tree and J48) can improve TPR 
and AUROC but only multiple trees (Random Forest) are able to provide weighted TPR > 0.70 
and AUROC > 0.79. Additional test have been done for different numbers of trees for RF method. 
Improvements of TPR & AUROC can be observed from 100 trees to 500 trees but almost no 
improvement was obtained with 1,000 trees.  
Table 2. Machine Learning classification models for interaction of 
magnolol with protein targets 
ML Method  TPR AUROC 
   
LibLINEAR  0.528 0.524 
BayesNet  0.609 0.686 
DecisionTable  0.632 0.707 
RandomTree  0.649 0.637 
J48  0.661 0.721 
RandomForest  0.701 0.791 
   
 
Therefore, the best model that can predict the magnolol interactions characterized by a specific 
biological activity with protein targets in specific organisms was obtained by Random Forest 
method using 500 trees. The model has the weighted TPR of 0.701 and AUROC of 0.790.  
  
The best model was used to predict the interactions using 79 types of ChEMBL biological 
activities for 47 protein targets and 18 organisms. Table 3 presents the predicted interactions 
greater than the averaged ones in the dataset with protein targets in Bos taurus, Homo sapiens, 
Mus musculus, Rattus norvegicus and Schistosoma mansoni (probability > 0.60). The entire list of 
magnolol predictions for all possible experimental combinations is presented as Supplementary 
Material.  
Table 3. Prediction of magnolol interactions with protein targets in Homo sapiens is greater than the average ones in the 
ChEMBL dataset. 
Organism  Standard Type Units Target Name 
    
Bos taurus  Inhibition % Glutathione S-transferase A1 
Homo sapiens  Activity % Prostaglandin E synthase 
Homo sapiens  Inhibition % Glutathione reductase homolog 
Homo sapiens  Inhibition % Glutathione reductase, putative 
Homo sapiens Inhibition % Glutathione S-transferase 
Homo sapiens  Inhibition % Glutathione S-transferase A1 
Homo sapiens  Inhibition % Probable glutathione reductase 2 
Homo sapiens Inhibition % Prostaglandin E synthase 
Homo sapiens  Inhibition % S-formylglutathione hydrolase 
Homo sapiens Inhibition % Superoxide dismutase [Cu-Zn] 
Mus musculus  Inhibition % Glutathione reductase, putative 
Rattus norvegicus  Activity % Prostaglandin E synthase 
Rattus norvegicus  Inhibition % Esterase D 
Rattus norvegicus Inhibition % Glutathione reductase, putative 
Rattus norvegicus  Inhibition % Glutathione S-transferase 
Rattus norvegicus  Inhibition % Glutathione S-transferase A1 
Rattus norvegicus  Inhibition % Glutathione synthetase 
Rattus norvegicus  Inhibition % Probable glutathione reductase 2 
Rattus norvegicus  Inhibition % Prostaglandin E synthase 
Rattus norvegicus  Inhibition % Superoxide dismutase [Cu-Zn] 
Schistosoma mansoni  Potency nM Thioredoxin glutathione reductase 
    
 
The magnolol experimental results in mouse were confirmed with the current theoretical model 
such as interactions with glutathione and superoxide dismutase. In addition, esterase D and 
prostaglandin E synthase are predicted as new targets. Similar with the experimental results in 
mouse, magnolol was predicted to have interactions in humans with glutathione and superoxide 
dismutase greater that the average interactions in the current dataset. In addition, new targets are 
predicted such as prostaglandin E synthase and Sformylglutathione hydrolase. The greater 
probability was obtained for the thioredoxin glutathione reductase in Schistosoma mansoni, a 
human parasite. Thus, the Random Forest model is confirming the most common protein target of 
magnolol among organisms as the glutathione reductase. The prediction model should be 
improved in future studies by using different types of information encoded in molecular 
descriptors.  
  
CONCLUSION  
In the present study, the experiment strongly evidenced that the various levels of oral magnolol 
administration played a vital role against the expression and existence of superoxide radicals (e.g., 
the expressions of SOD, GPX-1, and CAT at the transcriptional and post-transcriptional levels) in 
the mouse enzymatic antioxidant defense system. On the other hand, the oral magnolol 
administration also influenced the enzyme activities (e.g., MDA, MPO, NO, T-AOC and GSH) in 
the mouse non-enzymatic antioxidant defense system. In addition, the maintenance of magnolol 
antioxidant capacity to protect organisms varied with its doses and the physiological status of the 
corresponding cells in the Enterotoxigenic E. coli (ETEC)-induced and non-ETEC-induced mice.  
 
In order to complete the experimental results, a theoretical study predicted 79 types of 
biological activities of magnolol with 47 different protein targets in 18 organisms. The model 
dataset was based on the moving averages of the Rcpi molecular descriptors in specific 
experimental conditions such as activity type (with units), protein target and organism. Thus, six 
Machine Learning methods from Weka were tested to build the best classification model that can 
predict if the interactions of magnolol with protein targets is greater or less the average 
interactions of ChEMBL database. The best QSAR model was obtained with Random Forest 
method (10- fold cross-validation) and it has TPR of 0.701 and AUROC of 0.790 (test subset).  
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